Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection

  1. Melissa A. Sleda
  2. Khaly Diagne
  3. Victoria Mills Clifton
  4. Baihetiya Baierna
  5. Roman Manetsch
  6. Silvia N. J. Moreno

Reviewed by

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1021/acsinfecdis.5c01074
  2. Rapid Reviews Infectious Diseases

    Puran Sijwali

    Review 2: "Legacy 4(1H)-Quinolone Scaffolds Activity Against Acute and Chronic Toxoplasma gondii Infection"

    Overall, the work positions 4(1H)-quinolones as promising scaffolds for developing therapies that address the longstanding challenge of chronic toxoplasmosis. 

  3. Rapid Reviews Infectious Diseases

    Sébastien Besteiro

    Review 1: "Legacy 4(1H)-Quinolone Scaffolds Activity Against Acute and Chronic Toxoplasma gondii Infection"

    Overall, the work positions 4(1H)-quinolones as promising scaffolds for developing therapies that address the longstanding challenge of chronic toxoplasmosis. 

  5. Version published to 10.64898/2026.03.10.710892 on bioRxiv